ASCENDANCE BIOTECHNOLOGY, INC.

Profile

Company Names

ASCENDANCE BIOTECHNOLOGY, INC.

Addresses

200 BOSTON AVENUE, SUITE 1500, MEDFORD, MA 02155

Phone Numbers

781 391 0205

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$880,000.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2016-05-05 
$230,000.00 
$300,000.00 
$70,000.00 
Equity 
1
2015-12-09 
$650,000.00 
$750,000.00 
$100,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MORTON 
 
COLLINS 
DIRECTOR
ASCENDANCE BIOTECHNOLOGY, INC.   |  KOPIN CORP   |  INOVIO PHARMACEUTICALS, INC.
JEFFREY 
 
JANUS 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
ASCENDANCE BIOTECHNOLOGY, INC.
JEFFREY 
D. 
JANUS 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
ASCENDANCE BIOTECHNOLOGY, INC.
MARTIN 
J. 
JOYCE 
EXECUTIVE OFFICER
ALDEYRA THERAPEUTICS, INC.   |  ASCENDANCE BIOTECHNOLOGY, INC.
ALFRED 
D. 
KINGSLEY 
DIRECTOR
ONCOCYTE CORP   |  ASCENDANCE BIOTECHNOLOGY, INC.   |  AGEX THERAPEUTICS, INC.
JOHN 
K 
MCGEEHAN 
EXECUTIVE OFFICER, PROMOTER
ASCENDANCE BIOTECHNOLOGY, INC.
JOHN 
K. 
MCGEEHAN 
EXECUTIVE OFFICER, PROMOTER
ASCENDANCE BIOTECHNOLOGY, INC.
MICHAEL 
D. 
WEST 
DIRECTOR
ASCENDANCE BIOTECHNOLOGY, INC.   |  AGEX THERAPEUTICS, INC.
ROBERT 
G. 
WILKENS 
DIRECTOR
ASCENDANCE BIOTECHNOLOGY, INC.
VINCENT 
R, JR 
ZURAWSKI 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
ASCENDANCE BIOTECHNOLOGY, INC.
VINCENT 
R., JR. 
ZURAWSKI 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
ASCENDANCE BIOTECHNOLOGY, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-05-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-05-05 
2015-12-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-09 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#